Netherlands
Tuberculosis profile
Population  2013 17 million
Estimates of TB burden * 2013 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.02 (0.019–0.02) 0.12 (0.12–0.12)
Mortality (HIV+TB only) <0.01 (<0.01–<0.01) 0.03 (0.02–0.04)
Prevalence  (includes HIV+TB) 1.3 (0.54–2.3) 7.6 (3.2–14)
Incidence  (includes HIV+TB) 1 (0.95–1.1) 6.1 (5.7–6.7)
Incidence (HIV+TB only) 0.04 (0.037–0.044) 0.24 (0.22–0.26)
Case detection, all forms (%) 81 (74–88)    
Estimates of MDR-TB burden * 2013   New   Retreatment
% of TB cases with MDR-TB 2 (0.81–4.1) 33 (15–57)
MDR-TB cases among notified pulmonary
TB cases
9 (4–17) 11 (5–19)
TB case notifications 2013 New ** Relapse
Pulmonary, bacteriologically confirmed 368   17
Pulmonary, clinically diagnosed 60   1
Extrapulmonary 379   7
       
Total new and relapse 832    
Previously treated, excluding relapses 16    
Total cases notified 848    
Among 831 new and relapse cases:
32 (4%) cases aged under 15 years; male:female ratio: 1.5
Reported cases of RR-/MDR-TB 2013 New Retreatment Total **
Cases tested for RR-/MDR-TB 531 (144%) 28 (68%) 560
Laboratory-confirmed RR-/MDR-TB cases     19
Patients started on MDR-TB treatment     16
TB/HIV 2013 Number (%)
TB patients with known HIV status 432 (51)
HIV-positive TB patients 17 (4)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Treatment success rate (%)
New and relapse cases registered in 2012 83
Previously treated cases, excluding relapse, registered in 2012 64
HIV-positive TB cases, all types, registered in 2012  
RR-/MDR-TB cases started on second-line treatment in 2011 65
XDR-TB cases started on second-line treatment in 2011  
Laboratories 2013  
Is second-line drug susceptibility testing available? Yes, in country
Financing TB control 2014  
National TB programme budget (US$ millions) 43
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2015-08-31 Data: www.who.int/tb/data